The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
tert-butyl 3-(2-(8-(2-aminophenylamino)-8-oxooctanamido)thiazol-4-yl)phenylcarbamate ID: ALA4277593
PubChem CID: 145984617
Max Phase: Preclinical
Molecular Formula: C28H35N5O4S
Molecular Weight: 537.69
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)(C)OC(=O)Nc1cccc(-c2csc(NC(=O)CCCCCCC(=O)Nc3ccccc3N)n2)c1
Standard InChI: InChI=1S/C28H35N5O4S/c1-28(2,3)37-27(36)30-20-12-10-11-19(17-20)23-18-38-26(32-23)33-25(35)16-7-5-4-6-15-24(34)31-22-14-9-8-13-21(22)29/h8-14,17-18H,4-7,15-16,29H2,1-3H3,(H,30,36)(H,31,34)(H,32,33,35)
Standard InChI Key: SSGXGSMTAIQPMA-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 40 0 0 0 0 0 0 0 0999 V2000
6.0383 -21.8622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0424 -22.6835 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.7480 -21.4500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7438 -20.6287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4552 -20.2145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4514 -19.3940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7369 -18.9882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0249 -19.4048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0322 -20.2240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1683 -20.6250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3285 -21.4572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6187 -21.8694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9048 -21.4644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1951 -21.8766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4812 -21.4716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4770 -20.6503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7631 -20.2412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7589 -19.4199 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0534 -20.6575 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.4687 -19.0077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2212 -19.3342 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
3.7690 -18.7200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3527 -18.0143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5501 -18.1884 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6853 -17.2619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5012 -17.1748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8297 -16.4233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3417 -15.7595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5214 -15.8522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1966 -16.6040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0353 -15.1912 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3612 -14.4377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8751 -13.7766 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.1772 -14.3452 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2010 -13.0231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7108 -12.3662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0170 -12.9306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6031 -12.3115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
1 3 1 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
5 10 1 0
1 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
17 19 2 0
18 20 1 0
20 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 20 2 0
23 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 25 1 0
29 31 1 0
31 32 1 0
32 33 1 0
32 34 2 0
33 35 1 0
35 36 1 0
35 37 1 0
35 38 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 537.69Molecular Weight (Monoisotopic): 537.2410AlogP: 6.66#Rotatable Bonds: 11Polar Surface Area: 135.44Molecular Species: NEUTRALHBA: 7HBD: 4#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 5#RO5 Violations (Lipinski): 2CX Acidic pKa: 7.96CX Basic pKa: 3.45CX LogP: 5.71CX LogD: 5.61Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.16Np Likeness Score: -1.43
References 1. Adhikari N, Amin SA, Trivedi P, Jha T, Ghosh B.. (2018) HDAC3 is a potential validated target for cancer: An overview on the benzamide-based selective HDAC3 inhibitors through comparative SAR/QSAR/QAAR approaches., 157 [PMID:30179749 ] [10.1016/j.ejmech.2018.08.081 ]